Skip to content

Clinical trials

Observational Thrombocythemia, Essential trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Phase: Observational Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20074
20081
20093
20101
20121
20161
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Icahn School of Medicine at Mount Sinai4
UNC Lineberger Comprehensive Cancer Center2
City of Hope Medical Center1
Incyte Corporation1
MPN Research Foundation1
National Institutes of Health Clinical Center (CC)1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1
University of Utah1
Vanderbilt University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential13
Polycythemia Vera12
Primary Myelofibrosis12
Myeloproliferative Disorders11
Blast Crisis6
Burkitt Lymphoma5
Immunoblastic Lymphadenopathy5
Immunoglobulin Light-chain Amyloidosis5
Intraocular Lymphoma5
Leukemia, Biphenotypic, Acute5

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.